by Cathy Alinovi | Apr 26, 2019 | AAFCO, Latest News, Regulatory Updates
Just released, draft guidance from the FDA to companies regarding how to initiate a voluntary recall. Target audience for this compliance policy is any manufacturer under FDA jurisdiction (not just pet food companies). While many of you are probably signed up to...
by Cathy Alinovi | Apr 18, 2019 | Latest News, Regulatory Updates
Standing up for manufacturer’s rights is a foundational effort of Next Gen PFMA. In January (2019), we were notified of illegal seizure of frozen raw pet milk by the New Jersey Department of Health (NJDOH). The NJDOH incorrectly cited human food law (Title 24),...
by Cathy Alinovi | Mar 25, 2019 | FSMA, Latest News, Our Stories, Regulatory Updates
Given Next Gen PFMA represents manufactures of real pet food, at first glance, it may seem illogical to talk about the produce industry; however, the produce industry is regulated by the same agency as the pet food industry: the FDA. Therefore, this should prove a...
by Cathy Alinovi | Jan 29, 2019 | Latest News, Our Stories, Regulatory Updates
As an industry playing nice doesn’t seem to be creating any advantage. Twenty raw food recalls occurred in 2018 – in only one case was illness associated with the product; the manufacturer in question was not using USDA sourced and passed meats. We could...
by Cathy Alinovi | Jan 28, 2019 | AAFCO, AAFCO Meetings, FSMA, Labeling Updates, Latest News, Regulatory Updates
Most notable was the ongoing government shutdown meant no members of FDA were present – normally 20+ members of FDA attend AAFCO meetings. That brings our biggest disappointment as we were waiting for FDA feedback after our conversation in December. We had asked...
by Cathy Alinovi | Nov 13, 2018 | FSMA, Latest News, Regulatory Updates
On November 5, the US Food and Drug Administration (FDA) released their final guidance regarding Mandatory Recall Authority as interpreted from the Food Safety Modernization Act (FSMA). Simply based on title, this new guidance document gives the impression the FDA now...